Biblio Discovery — Demo Discovery Service

4 results for "Li-Peng Lin"

Showing 1–4 · 0.00 seconds · RSS

  1. Journal Article Full text

    Erdheim-Chester disease with asymmetric talus involvement: A case report

    Xia, Qin; Tao, Cheng; Zhu, Ke-Wei et al.

    World J Clin Cases · 2020 · English · PubMed Central

    BACKGROUND: Erdheim-Chester disease (ECD) is a rare multi-system or multi-organ histiocytic proliferative disease with diverse clinical manifestations, and the development of the disease is complex, which makes clinical diagnosis and treatment difficult. The characteristic clinical manifestations…

  2. Journal Article

    Prognostic features of biochemical recurrence of prostate cancer following radical prostatectomy based on diffusion kurtosis imaging

    Li-Peng Lin; Xian-Wen Cheng; Juan Chen et al.

    Cancer Imaging, Vol. 26 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Objectives To evaluate characteristics of diffusion kurtosis imaging (DKI), baseline prostate-specific antigen (PSA) and postoperative histopathological findings associated with biochemical recurrence (BCR) of prostate cancer (PCa) after radical prostatectomy (RP). Materials & Methods…

  3. Journal Article Full text

    Human herpesvirus 6B glycoprotein B postfusion structure, vulnerability mapping, and receptor recognition

    Xie, Chu; Fang, Xin-Yan; Liu, Yuan-Tao et al.

    PLoS Pathog · 2025 · English · PubMed Central

    Human herpesvirus 6B (HHV-6B), a β-herpesvirus that significantly threatens immunocompromised individuals, currently lacks targeted antiviral therapies or vaccines. Glycoprotein B (gB), the primary mediator of membrane fusion during viral entry, is a key target for neutralizing antibody (nAb) and…

  4. Journal Article Full text

    Applications of Artificial Intelligence in Biotech Drug Discovery and Product Development

    Liu, Yuan‐Tao; Zhang, Le‐Le; Jiang, Zi‐Ying et al.

    MedComm (2020) · 2025 · English · PubMed Central

    Artificial intelligence (AI) is revolutionizing biotechnology by transforming the landscape of therapeutic development. Traditional drug discovery faces persistent challenges, including high attrition rates, billion‐dollar costs, and timelines exceeding a decade. Recent advances in AI—particularly…